NAMA
PRME icon

Nikko Asset Management Americas’s Prime Medicine PRME Stock Holding History

Nikko Asset Management Americas’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Sell
2,940,793
-304,713
-9% -$1.16M 0.14% 84
2025
Q4 		$11.2M Sell
3,245,506
-384,418
-11% -$1.71M 0.13% 87
2025
Q3 		$20M Buy
3,629,924
+2,040,807
+128% +$8.29M 0.19% 81
2025
Q2 		$3.89M Sell
1,589,117
-1,336,906
-46% -$2.06M 0.04% 110
2025
Q1 		$5.82M Sell
2,926,023
-164,157
-5% -$419K 0.08% 95
2024
Q4 		$9.02M Sell
3,090,180
-92,275
-3% -$324K 0.1% 87
2024
Q3 		$12.3M Sell
3,182,455
-55,930
-2% -$259K 0.14% 83
2024
Q2 		$16.5M Sell
3,238,385
-126,278
-4% -$766K 0.19% 72
2024
Q1 		$23.5M Sell
3,364,663
-154,366
-4% -$1.17M 0.23% 65
2023
Q4 		$31.2M Sell
3,519,029
-115,819
-3% -$892K 0.3% 58
2023
Q3 		$34.6M Buy
3,634,848
+570,232
+19% +$7.41M 0.41% 52
2023
Q2 		$44.8M Buy
3,064,616
+2,065,283
+207% +$28.8M 0.47% 44
2023
Q1 		$11M Buy
999,333
+511,107
+105% +$8.33M 0.13% 78
2022
Q4 		$9.04M Buy
+488,226
New +$8.82M 0.13% 88

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Nikko Asset Management Americas's PRME Position: Q1 2026 in Review

Nikko Asset Management Americas reduced its Prime Medicine (PRME) stake by 9.4% in Q1 2026, selling an estimated $1.16M and leaving 2,940,793 shares worth $10.2M. The position accounts for 0.14% of the portfolio, ranked #84.

Nikko Asset Management Americas first reported a position in PRME in Q4 2022 and has held it in 14 quarters since. The position peaked at $44.8M in Q2 2023. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Nikko Asset Management Americas held 2,940,793 shares of Prime Medicine worth $10.2M as of Q1 2026.
  • Nikko Asset Management Americas sold 304,713 Prime Medicine shares in Q1 2026, an estimated $1.16M.
  • Prime Medicine made up 0.14% of Nikko Asset Management Americas's portfolio in Q1 2026, its #84 holding.
  • Nikko Asset Management Americas first reported a position in Prime Medicine in Q4 2022 and has held it in 14 quarters since.
  • Nikko Asset Management Americas's Prime Medicine position peaked at $44.8M in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Nikko Asset Management Americas's 13F filing for Q1 2026, filed 7 May 2026.